{
    "eid": "2-s2.0-85107053622",
    "title": "Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates",
    "cover-date": "2021-05-13",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Plant Science",
            "@code": "1110",
            "@abbrev": "AGRI"
        }
    ],
    "keywords": [
        "COVID-19",
        "Fc fusion protein",
        "Nicotiana benthamiana",
        "plant-produced recombinant protein",
        "receptor-binding domain",
        "SARS-CoV-2",
        "subunit vaccine"
    ],
    "authors": [
        "Konlavat Siriwattananon",
        "Suwimon Manopwisedjaroen",
        "Balamurugan Shanmugaraj",
        "Kaewta Rattanapisit",
        "Supaporn Phumiamorn",
        "Sompong Sapsutthipas",
        "Sakalin Trisiriwanich",
        "Eakachai Prompetchara",
        "Chutitorn Ketloy",
        "Supranee Buranapraditkun",
        "Wassana Wijagkanalan",
        "Kittipan Tharakhet",
        "Papatsara Kaewpang",
        "Kantinan Leetanasaksakul",
        "Taratorn Kemthong",
        "Nutchanat Suttisan",
        "Suchinda Malaivijitnond",
        "Kiat Ruxrungtham",
        "Arunee Thitithanyanont",
        "Waranyoo Phoolcharoen"
    ],
    "citedby-count": 36,
    "ref-count": 105,
    "ref-list": [
        "Recombinant human dentin matrix protein 1 (hDMP1) expressed in Nicotiana benthamiana potentially induces osteogenic differentiation",
        "SARS-CoV-2 vaccines: status report",
        "Bats and Coronaviruses",
        "Plant molecular farming: opportunities and challenges",
        "The endoplasmic reticulum is a hub to sort proteins toward unconventional traffic pathways and endosymbiotic organelles",
        "Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein",
        "The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex",
        "Therapeutic recombinant protein production in plants: Challenges and opportunities",
        "Introduction to current and future protein therapeutics: a protein engineering perspective",
        "Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants",
        "Optimization of the production process and characterization of the yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1), a SARS vaccine candidate",
        "The SARS-CoV-2 vaccine pipeline: an overview",
        "Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with alum induces protective immunity and reduces immune enhancement",
        "Fc-fusion proteins: new developments and future perspectives",
        "The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza",
        "Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice",
        "Green giant\u2014a tiny chloroplast genome with mighty power to produce high\u2212value proteins: history and phylogeny",
        "High-level expression and enrichment of norovirus virus-like particles in T plants using modified geminiviral vectors",
        "Pilot production of SARS-CoV-2 related proteins in plants: a proof of concept for rapid repurposing of indoor farms into biomanufacturing facilities",
        "Current state-of-the-art in plant-based antibody production systems",
        "A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity",
        "Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model",
        "The immunobiology of aluminium adjuvants: how do they really work?",
        "First plant-made biologic approved",
        "A statistically defined endpoint titer determination method for immunoassays",
        "Production of virus-like particles for vaccines",
        "Magnifection\u2013a new platform for expressing recombinant vaccines in plants",
        "An overview of heterologous expression host systems for the production of recombinant proteins",
        "A randomized, controlled trial of ZMapp for ebola virus infection",
        "A plant-produced antigen elicits potent immune responses against West Nile virus in mice",
        "Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein",
        "Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies",
        "Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry",
        "Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines",
        "Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro",
        "Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want",
        "Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology",
        "Potential of plant biologics to tackle the epidemic like situations - case studies involving viral and bacterial candidates",
        "Fc-based cytokines: prospects for engineering superior therapeutics",
        "Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome",
        "Expression of the synthetic neutralizing epitope gene of porcine epidemic diarrhea virus in tobacco plants without nicotine",
        "Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine",
        "Strategies for optimization of heterologous protein expression in E. coli: roadblocks and reinforcements",
        "Industrialization of mAb production technology: the bioprocessing industry at a crossroads",
        "Characterization of a chemically modified plant cell culture expressed human a-Galactosidase-A enzyme for treatment of Fabry disease",
        "Heterologus protein expression in different host systems",
        "Transient plant transformation mediated by Agrobacterium tumefaciens: principles, methods and applications",
        "Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig",
        "Structure, function, and evolution of coronavirus spike proteins",
        "Inhibitory Fc\u03b3 receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies",
        "Coronavirus disease 2019 (COVID-19): current status and future perspectives",
        "Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia",
        "Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus",
        "RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response",
        "The production of recombinant pharmaceutical proteins in plants",
        "Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants",
        "Emerging novel coronavirus (2019-nCoV)\u2014current scenario, evolutionary perspective based on genome analysis and recent developments",
        "Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Emerging Zoonotic Respiratory Pathogen in Humans",
        "Towards an understanding of the adjuvant action of aluminium",
        "Plant bioreactors for pharmaceuticals",
        "Molecular pharming\u2019s foot in the FDA\u2019s door: protalix\u2019s trailblazing story",
        "Plant\u2212made pharmaceuticals: leading products and production platforms",
        "Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana",
        "A plant- derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults",
        "Severe acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccine",
        "The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement",
        "SARS-CoV-2 and coronavirus disease 2019: what we know so far",
        "Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics",
        "Plant-produced anti-enterovirus 71 (EV71) monoclonal antibody efficiently protects mice against EV71 infection",
        "Structural and in vitro functional analyses of novel plant-produced anti-Human PD1 antibody",
        "Rapid and scalable production of functional anti-coronavirus monoclonal antibody CR3022 in plants",
        "Plant-produced recombinant Osteopontin-Fc fusion protein enhanced osteogenesis",
        "Plant-produced recombinant SARS-CoV-2 receptor-binding domain; an economical, scalable biomaterial source for COVID-19 diagnosis",
        "A perspective on the development of plant-made vaccines in the fight against Ebola virus",
        "Third international conference on plant-based vaccines and antibodies",
        "The molecular biology of coronaviruses",
        "Plant-based oral vaccines against zoonotic and non-zoonotic diseases",
        "Plant molecular farming: A viable platform for recombinant biopharmaceutical production",
        "Addressing demand for recombinant biopharmaceuticals in the COVID-19 era",
        "Monoclonal antibodies B38 and H4 produced in Nicotiana benthamiana neutralize SARS-CoV-2 in vitro",
        "Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)",
        "2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies",
        "A review of coronavirus disease-2019 (COVID-19)",
        "Development of plant-produced recombinant ACE2-Fc fusion protein as a potential therapeutic agent against SARS-CoV-2",
        "Immunogenicity of a DNA vaccine candidate for COVID-19",
        "Discovery and development of biopharmaceuticals: current issues",
        "Cytokine storm intervention in the early stages of COVID-19 pneumonia",
        "Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR",
        "Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants",
        "The endoplasmic reticulum-gateway of the secretory pathway",
        "Unexpected receptor functional mimicry elucidates activation of coronavirus fusion",
        "Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on the middle east respiratory syndrome coronavirus spike glycoprotein to avoid neutralization escape",
        "Phase 1 trial of a candidate recombinant virus-like particle vaccine for COVID-19 disease produced in plants",
        "Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18-49 years of age",
        "Severe COVID-19: a review of recent progress with a look toward the future",
        "Engineering of Fc fragments with optimized physicochemical properties implying improvement of clinical potentials for Fc-based therapeutics",
        "Plants as factories for human pharmaceuticals: applications and challenges",
        "Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains",
        "COVID-19 pathophysiology: a review",
        "Induction of toxin-specific neutralizing immunity by molecularly uniform rice-based oral cholera toxin B subunit vaccine without plant-associated sugar modification",
        "Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus",
        "Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice",
        "Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin",
        "Receptor-binding domain as a target for developing SARS vaccines"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "120713134",
            "affilname": "Ltd.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/120713134",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nontaburi",
            "@id": "60015728",
            "affilname": "Thailand Ministry of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015728",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60011947",
            "affilname": "Thailand National Center for Genetic Engineering and Biotechnology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011947",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Baiya Phytopharm Co., Ltd.",
        "Department of Disease Control",
        "Chulalongkorn University",
        "Ministry of Public Health",
        "TSRI"
    ]
}